| Introduction |
|
iii | (2) |
|
|
|
|
|
| Preface |
|
v | (2) |
| Contributors |
|
vii | |
|
1. Cellular Sources and Steady-State Levels of Reactive Oxygen Species |
|
|
1 | (26) |
|
|
|
|
|
|
|
|
|
|
|
|
|
1 | (2) |
|
II. Superoxide Anion and Hydrogen Peroxide |
|
|
3 | (7) |
|
|
|
10 | (5) |
|
IV. Alkyl and Peroxyl Radicals |
|
|
15 | (2) |
|
V. Electronically Excited Species |
|
|
17 | (2) |
|
|
|
19 | (1) |
|
|
|
20 | (7) |
|
2. Cytotoxicity of Oxyradicals and the Evolution of Superoxide Dismutases |
|
|
27 | (22) |
|
|
|
|
|
|
|
|
27 | (1) |
|
II. Chemical Properties of Dioxygen and Its Partially Reduced Intermediates |
|
|
28 | (3) |
|
III. Sources of Partially Reduced Oxygen Intermediates |
|
|
31 | (1) |
|
IV. Role of Oxyradicals in DNA Damage and Mutagenesis |
|
|
32 | (1) |
|
V. Evolution of Defense Mechanisms Against Oxidative Damages |
|
|
32 | (6) |
|
|
|
38 | (1) |
|
|
|
39 | (10) |
|
3. Oxygen Conformance and Cellular Regulation |
|
|
49 | (18) |
|
|
|
|
|
|
|
|
49 | (3) |
|
II. Mechanisms of Respiratory Control |
|
|
52 | (7) |
|
III. Conformance of Antioxidant and Detoxication Systems to Hypoxia |
|
|
59 | (2) |
|
IV. Perspective and Conclusions |
|
|
61 | (1) |
|
|
|
62 | (5) |
|
4. Metabolic Effects of Hyperoxia: Lessons from Permanent Cell Lines |
|
|
67 | (8) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
67 | (1) |
|
II. Oxygen Toxicity and Tolerance: CHO Cells |
|
|
68 | (1) |
|
|
|
69 | (2) |
|
IV. Differential Gene Expression Studies |
|
|
71 | (2) |
|
|
|
73 | (2) |
|
5. Transgenic Models for the Study of Lung Injury and Repair: Integration of Molecular, Functional, and Cellular Approaches |
|
|
75 | (24) |
|
|
|
|
|
|
|
|
|
|
|
|
|
75 | (1) |
|
II. Eukaryotic Antioxidant Systems |
|
|
76 | (3) |
|
III. Manipulation of the Murine Genome |
|
|
79 | (2) |
|
IV. Characterizing Transgenic Mice |
|
|
81 | (1) |
|
V. Targeted Gene Disruption |
|
|
81 | (3) |
|
VI. Murine Models for Genetically Altered Antioxidant Enzymes |
|
|
84 | (1) |
|
|
|
85 | (3) |
|
VIII. Biological Viral Vectors |
|
|
88 | (3) |
|
|
|
91 | (8) |
|
6. Glutathione Cycling in Oxidative Stress |
|
|
99 | (24) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99 | (1) |
|
II. Glutathione Redox Cycling |
|
|
99 | (2) |
|
III. Glutathione Synthesis |
|
|
101 | (2) |
|
IV. GSH in Oxidative Stress and Xenobiotic Metabolism |
|
|
103 | (8) |
|
|
|
111 | (1) |
|
|
|
112 | (11) |
|
7. Oxidative Stress and Cell Proliferation |
|
|
123 | (16) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
123 | (1) |
|
II. ROS as Second Messengers |
|
|
124 | (1) |
|
III. Control of Cell Growth |
|
|
124 | (3) |
|
IV. Stimulation of Cellular Proliferation by ROS |
|
|
127 | (1) |
|
V. Inhibition of Proliferation by ROS |
|
|
128 | (1) |
|
|
|
129 | (1) |
|
VII. Influence of ROS on Growth-Related Signaling Pathways |
|
|
130 | (2) |
|
VIII. Mechanisms of ROS-Induced Changes in Cell Growth |
|
|
132 | (1) |
|
|
|
133 | (1) |
|
|
|
133 | (6) |
|
8. Oxidative Stress and Aging |
|
|
139 | (30) |
|
|
|
|
|
|
|
|
|
|
|
|
|
139 | (1) |
|
II. Transgenic, Knockout, and Mutant Animal Models |
|
|
140 | (4) |
|
III. Mitochondrial Dysfunction |
|
|
144 | (3) |
|
IV. Caloric Restriction and Reduction of Oxidative Stress |
|
|
147 | (4) |
|
V. Oxidative Modification of Proteins During Aging |
|
|
151 | (5) |
|
VI. Oxidative Stress and Lung Aging |
|
|
156 | (2) |
|
|
|
158 | (1) |
|
|
|
158 | (11) |
|
9. Vascular Smooth Muscle Oxygen Sensing |
|
|
169 | (36) |
|
|
|
|
|
|
|
|
169 | (1) |
|
II. O(2) Sensors and Transduction Systems in Nonvascular Cells |
|
|
170 | (2) |
|
III. Vascular Smooth Muscle Responses to Hypoxia |
|
|
172 | (2) |
|
IV. General Comments on Smooth Muscle Signal Transduction Mechanisms |
|
|
174 | (2) |
|
V. O(2)-Sensitive Transduction Systems in sVSM and pVSM |
|
|
176 | (17) |
|
|
|
193 | (2) |
|
|
|
195 | (10) |
|
10. Oxygen Control of Erythropoietin Gene Expression |
|
|
205 | (16) |
|
|
|
|
|
|
|
|
|
|
|
|
|
205 | (1) |
|
II. Physiology of Erythropoietin Production |
|
|
206 | (2) |
|
III. Molecular Aspects of Erythropoietin Production |
|
|
208 | (4) |
|
IV. Mechanisms of Oxygen Sensing |
|
|
212 | (5) |
|
|
|
217 | (4) |
|
11. Antioxidant Response Element (ARE) and the Regulation of Gene Expression |
|
|
221 | (22) |
|
|
|
|
|
|
|
|
221 | (1) |
|
II. Induction of Detoxifying Enzymes and Cellular Protection Against Oxidative Stress |
|
|
222 | (3) |
|
III. Antioxidant Response Element (ARE) and Regulation of Detoxifying Enzyme Genes |
|
|
225 | (4) |
|
IV. Antioxidant Response Element-Nuclear Protein Interaction |
|
|
229 | (3) |
|
V. Signal Transduction Mediated by ARE |
|
|
232 | (4) |
|
|
|
236 | (1) |
|
|
|
237 | (6) |
|
12. Oxidant Regulation of Cytokine Gene Expression |
|
|
243 | (36) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
243 | (7) |
|
II. Regulation of Neutrophil Recruitment and Activation |
|
|
250 | (2) |
|
III. Reactive Oxygen Intermediates |
|
|
252 | (2) |
|
IV. Cytokine Induction of ROI |
|
|
254 | (1) |
|
V. ROI Induction of Cytokines |
|
|
255 | (6) |
|
VI. Nuclear Mechanisms of ROI Induction of Cytokines |
|
|
261 | (1) |
|
|
|
261 | (1) |
|
|
|
262 | (17) |
|
13. Role of Antioxidant Enzymes in the Cancer Phenotype |
|
|
279 | (30) |
|
|
|
|
|
|
|
|
|
|
|
|
|
279 | (2) |
|
II. Levels of Antioxidant Enzymes in Cancer Cells |
|
|
281 | (5) |
|
III. Do Changes in Antioxidant Enzyme Levels Cause Cancer? |
|
|
286 | (3) |
|
|
|
289 | (5) |
|
V. Tumor Suppressor Genes and Dominant Oncogenes |
|
|
294 | (5) |
|
VI. Possible Role of Catalase |
|
|
299 | (1) |
|
VII. Role of Nitric Oxide |
|
|
299 | (2) |
|
|
|
301 | (1) |
|
|
|
301 | (8) |
|
14. Manifestations and Mechanisms of Ischemia/Reperfusion Injury to the Lung |
|
|
309 | (30) |
|
|
|
|
|
|
|
|
|
|
|
I. Ischemia/Reperfusion Injury to Tissues |
|
|
309 | (8) |
|
II. Ischemia/Reperfusion Injury to the Lung |
|
|
317 | (10) |
|
|
|
327 | (1) |
|
|
|
328 | (11) |
|
15. Regulation of Alveolar Epithelial Na(+) Channel Expression and Activity in Hyperoxia |
|
|
339 | (28) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
339 | (1) |
|
II. Active Ion Transport Across the Mammalian Alveolar Epithelium |
|
|
340 | (2) |
|
III. Evidence for the Existence of Sodium Channels in ATII Cells |
|
|
342 | (8) |
|
IV. Evidence for the Existence of Na(+), K(+)-ATPase in ATII Cells |
|
|
350 | (1) |
|
V. NA(+) Transport During Sublethal Oxidant Injury |
|
|
351 | (5) |
|
VI. Oxidant Regulation of Gene Expression |
|
|
356 | (4) |
|
|
|
360 | (1) |
|
|
|
361 | (6) |
|
16. Oxidative Stress and Antioxidants in Respiratory Tract Lining Fluids |
|
|
367 | (32) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
367 | (1) |
|
II. Respiratory Tract Lining Fluids (RTLFs) |
|
|
368 | (2) |
|
|
|
370 | (2) |
|
IV. What Do We Know About Antioxidant Composition of RTLFs? |
|
|
372 | (7) |
|
V. Other Extracellular Antioxidants |
|
|
379 | (1) |
|
VI. Oxidative Stresses Affecting FTLFs |
|
|
379 | (3) |
|
VII. Plasma as a Model for RTLFs |
|
|
382 | (2) |
|
VIII. RTLF Interactions with Cell Surfaces |
|
|
384 | (1) |
|
IX. Implications for Cell Culture Research |
|
|
385 | (1) |
|
|
|
386 | (1) |
|
XI. Overview and Future Directions |
|
|
387 | (1) |
|
|
|
388 | (11) |
|
17. Lung Antioxidant Enzyme Gene Expression and Tolerance to Hyperoxia |
|
|
399 | (26) |
|
|
|
|
|
|
|
|
|
|
|
|
|
399 | (1) |
|
II. Endogenous Tolerance to Oxygen |
|
|
400 | (7) |
|
III. Pharmacological and Experimental Tolerance to Hyperoxia |
|
|
407 | (5) |
|
IV. Antioxidant Enzyme RNA-Binding Proteins |
|
|
412 | (2) |
|
V. Signal Transduction Pathways in the Regulation of AOE Expression |
|
|
414 | (1) |
|
VI. Uncoordinate Regulation of Antioxidant Enzyme Expression in the Lung |
|
|
415 | (1) |
|
|
|
416 | (1) |
|
|
|
417 | (8) |
| Author Index |
|
425 | (56) |
| Subject Index |
|
481 | |